Glow Collagen becomes the 2 nd runner up in the best brands category in 2021 during the Annual Award Ceremony of A Baur & Company (pvt) Ltd, the sole Importer and Distributor of Mega Lifesciences products to Sri Lanka including Glow Collagen.
This talk show is a Mega We care initiative, where Chief coach of Mega Lifesciences Khun Vivek Dhawan is in conversation with Chief wellness officer Dr. Sant; to help us search for the truth behind all the stories we hear in news on Covid.
With so much information on Covid, (a lot of which is conflicting) we the common people are often left confused.
This endeavor is about a search for finding simple answers to our everyday questions on how to live with Covid?
We do not aim to find faults or crucify anyone.
It is all about a scientific journey to get around the medical jargon and to make sense of it for the common person.
It is not a claim to fame that we know all.
Using our judgement after studying the available evidence by the experts, it is an endeavour to bring this information to you.
So you can help yourself to stay healthy as long as you live.
It is about good health by yourself.
Despite the global spread of Covid-19, this year’s annual Best Under A Billion list highlights the resilience of 200 publicly listed small and midsized companies in the Asia-Pacific region with sales under $1 billion. Their sound financial figures reflect how well these companies coped in the midst of a global pandemic. No surprise: Healthcare and pharmaceutical-related companies were standouts while tech and logistics firms linked to the global e-commerce boom also benefited. As proof of BUB companies’ sustainable success, 42 were returnees from the previous year. This includes Taiwan’s Aspeed, now on the list for a notable eight years in a row.
We’ve highlighted eight companies from the list with businesses that helped alleviate the pandemic’s effects.
While its agrochemical business faced a tough year, sales of this India-based agri-biotech company were up 12% and net profit surged for the year to March, thanks to a real-time Covid-19 PCR detection kit developed by a subsidiary.
Kilpest became the first Indian company to get approval from the Food & Drug Administration for emergency use of this kit in the U.S.
This Thailand-based pharmaceutical company’s revenue grew 11% to $402 million in 2020 as demand for its dietary supplements, drugs and vitamins rose during the pandemic.Last year, the company acquired Futamed Pharmaceuticals, now renamed Mega Lifesciences Indonesia.
Working from home during the pandemic spurred demand for Optim’s remote working tools.As a result, the Japanese company’s net profit rocketed tenfold to $12 million for the year ended in March. Aside from its telework-support software, its AI camera gained traction last year, used for tracking areas of congestion like staff canteens.
This clinical laboratory company’s 2020 net profit grew 28% to $18 million. The company introduced new services last year such as drive-in services and teleconsultation, and it is the first private company in Indonesia to use an automated system to help the government increase Covid-19 PCR testing.
This Singapore-based company’s 2020 revenue climbed 85% to an all-time high of $435 million, based on robust sales of its gloves, used in healthcare, tech and other sectors. Cleanroom glove sales grew 65% year-on-year, and medical glove sales increased 16% as Covid-19 boosted demand.
Hong Kong-based respiratory device maker’s 2020 revenue doubled to $149 million as sales from its respiratory business soared by 286% due to pandemic demand. Last year, the company tripled its production capacity in two months and doubled its workforce.
This Australia-based logistics software developer saw a 23% revenue increase in 2020 to $288 million as the logistics industry got a boost from pandemic. The company’s logistics platform is used by top global freight forwarders such as DHL Global Forwarding and Yusen Logistics.
China’s WuXi Biologics’ 2020 revenue soared 41% to $813 million as it expanded capacity to develop new treatments and vaccines for Covid-19. Last year, its vaccine manufacturing business signed contracts valued at over $3.2 billion.With reporting by John Kang, Danielle Keeton-Olsen, Zinnia Lee, Ramakrishnan Narayanan, Amit Prakash, James Simms and Yue Wang.
METHODOLOGY
This list is meant to identify companies with long-term sustainable performance across a variety of metrics. From a universe of 20,000 publicly traded companies in the Asia-Pacific region with annual revenue above $10 million and below $1 billion, only these 200 companies were selected.
The companies on this list, which is unranked, were selected based on a composite score that incorporated their overall track record in measures such as debt, sales and earnings-per-share growth over both the most recent fiscal one- and three-year periods, and the strongest one- and five-year average returns on equity.
Aside from quantitative criteria, qualitative screens were used as well, such as excluding companies with serious governance issues, questionable accounting, environmental concerns, management issues or legal troubles.
State-controlled and subsidiaries of larger companies were also excluded. The criteria also ensured a geographic diversity of companies from across the region.
The list uses full-year annual results, based on the latest publicly available figures as of Aug. 12, 2021 compiled by FactSet. All other research was done by Forbes Asia. The editors reserve the right to amend or remove any data or companies in light of new information after the list’s release.
Manufactured by Mega Lifesciences, Glow, the pioneering complete skin care nutrient brand in the Sri Lanka, which stands for “beauty from within” proudly commemorated its 10th anniversary. The anniversary celebrations set off at Park Street Mews amidst a vibrant extravaganza that portrayed the brand’s dynamic growth over a decade, emphasizing on and acknowledging the unwavering trust placed on Glow by its customers who have patronised the brand over the years. Beginning its journey in 2005, Glow was the first to introduce the concept of ‘beauty from within’ to customers. Since its introduction to the market, Glow has been endorsed by beauty queens and reputed professionals in the beauty care industry owing to its high quality and effective delivering of results. A brand that has played a key role in helping hundreds of customers to discover their true beauty, Glow is a combination of completely natural ingredients. As such, the product contains marine protein, hydrolyzed collagen, extracts of horsetail, pine bark, green tea, tomato, D-salina and grape seeds, Vitamins C and E and lemon bioflavonoids. Made with the perfect blend of natural ingredients, Glow is proven and guaranteed to have zero side effects, while promising a fair, smooth and radiant skin, which is even in tone. It also moisturizes your skin, protecting it from harmful substances and prevents premature ageing. Due to its rich Sillica content, which is from a plant commonly called horsetail and natural Vitamin E, Glow also improves hair and nails as well. What’s more, it has been certified by Spin Control Institute of France following clinical trials as a product that is 100 percent effective in improving colour, complexion, brightness and softness of the skin without any side effects, and is the only skin care nutrient in Sri Lanka that has been certified through such trials. Further, Glow is manufactured at a plant certified by Australian TGA (Therapeutic Goods Administration), Thai FDA, European Union and WHO standards. The overwhelming positive feedback Glow has received from its customers who have associated the product since its introduction, while continuing to use it stand testament to the brand’s commitment to provide only the best to its clients, and its success as the only complete skin care nutrient in the market. It is in this context, that the brand celebrated a decade of excellence, re-launching Glow to continue its success story and help thousands of individuals in Sri Lanka to look their best, with radiant and glowing skin that enhances beauty.Glow now stands for 10 years of trust and contribution towards the beauty of women in Sri Lanka. Glow can be purchased from pharmacies and supermarkets Island-wide and the general dosage is two capsules per day following breakfast and dinner. It can be consumed by anyone over age 18. Glow is imported and distributed in Sri Lanka by A Baur & Company (Pvt) Ltd, which is one of the most reputed companies in Sri Lanka. Glow is manufactured Mega Lifesciences, a world-class producer of nutritional and herbal supplements and OTC drugs. Headquartered in Bangkok, the company’s global footprint extends up to 31 countries across the globe, with state-of-the-art manufacturing plants in Thailand and Australia. Mega Lifesciences has been at the forefront of introducing innovative products that significantly contribute towards wellness, and it continues to journey on, to spread its commitment “We Care for Human Wellness”.
Glow’s recent anniversary event celebrated 10 years of dedication to beauty and glowing skin. Here are some highlights!
Mega Lifesciences celebrates International Women’s day in collaboration with Rotary Mid-City. Mega Lifesciences one of the leading pharmaceutical companies in the country with a mission to spread good health , beauty and human wellness among the people celebrated international women’s day in collaboration with Rotary Club Mid city at the Ceylon tourist board auditorium on Wednesday the 11 of the march’15. On this occasion Mega Lifesciences organized a health & beauty camp which conducted among the many other things a BMI test for all the members of rotary mid-city, inner wheel and other invitees. The BMI test is a good indicator of one’s health by measuring the height to weight ratio and correlated with the normal or standard values , qualified professionals at the event explained the significance of this measure, where the ideal BMI is anything between 18 and 25, above which its termed as overweight and beyond a BMI of 28 one is considered to be obese . Obesity is a root cause of many chronic ailments such as high blood pressure, high blood sugar and various forms of cancer. Mr Praveen Viswakumaran, Country Manager of Mega Lifesciences highlighted this fact and mentioned that in Sri Lanka 27% of the women and 17% of men are considered to be overweight. He also mentioned that obesity takes away years of one’s life and life off one’s years, hence its extremely important to manage one’s weight and try and keep it as close as possible to the normal values. Dr Anoma jayasinghe, the medical doctor of Sri Lankan airlines and Mihin Lanka and a Civial Aviation examiner who also happened to be one of the panelist at the function spoke elaborately on obesity and its implication on women’s health, she said that women should take time out to exercise and look after herself and her family so that many complications arising out of this condition could be prevented. In her words she mentioned that obesity causes harm to many internal body organs. In addition to BMI, Mega also conducted a skin analysis to check the health of one’s skin. There was another section which offered diet tips through a qualified dietician. The other panelists in the session Mrs Nayana Karunarate spoke about women empowerment and about how women can get what they want in life if they are focused on their goals and pursue it relentlessly. She also quoted her own example of how she wanted to be a hair dresser even while in ‘O’ Level and how she went about convincing her mother about her dream and looking back she feels that she has no regrets because she pursued her ambition with a lot of passion and dedication. She also emphasized the fact that a woman plays many roles in life and the only one of the two sexes blessed to give birth, which is indeed a matter of great pride for every woman. She summed up by saying that self help is the best help and a woman should know how to look after herself, she also emphasized the importance of staying healthy, well groomed and beautiful. Finally, Mrs Shehara Rizly, the editor of Lanka Women spoke about the role of media and women’s rights in particular. Mega Lifesciences also showcased their brands that had achieved certain milestones during its 12 years of operations in Sri Lanka. GLOW the complete skin care nutrient for a radiant and glowing skin, had just completed ten years of contribution towards the beauty of women in Sri Lanka, this year. NNO the first Nourishing Night Oil to be launched in Sri Lanka was also formally launched on an international women’s day in 2008 and having completed 7 years of nourishing the lives of women in Sri Lanka. NNO continues to nourish, revitalize and rejuvenate the skin. NNO improves the moisture, firmness, elasticity and softness of the skin when used every night before going to bed. Vitavite is the first serum for night time use to be launched in Sri Lanka. Vitavite promises a fair and beautiful skin, free from dark spots, acne marks, blemishes and sun spots. Through Vitavite, Mega Lifesciences aims to promote the concept of equality, fairness and kindness among the public at large and its users in particular. Pynocare is another product which is the first and only oral de-pigmentation solution in Sri Lanka, launched about 2 years ago in this country. Hi Green is a weight management capsule containing an active extract of green tea leaves. The catechins in Hi Green improves energy expenditure, metabolic rate and ensures an overall weight reduction of 4.6% as well as reduction in the waist circumference of about 4.8% in 8 to 12 weeks time. Lastly, a product to relieve stress and pep up one’s life in the form of a daily multivitamin and mineral supplement called Ginsomin. Ginsomin improves performance, energy and protection all day long. The function ended on a healthy note with a message…stay healthy…stay beautiful
Anyone who has ever exchanged business cards with Vivek Dhawan will be puzzled by one of the positions he holds at Mega LifeSciences Plc. Beside the word CEO is the title of “Chief Coach”. The latter is equally important to the people who work with Mr Dhawan at the company he has led since 1986.
“Where does the word coach come from? Football?” I ask him. “No,” he answers, though he is a big fan. It is team sport in general that inspires him. “I watch football. I love to watch Arsenal. I love to watch Barcelona. I love to see the way they play. From the movement of the ball, you can say everybody is involved in the game. There’s no one hero.”
Making sure everyone is involved is the way Mr Dhawan runs the business of Mega LifeSciences, the company that has transformed itself from a contract manufacturer of medicine capsules. Over the past three decades it has evolved into a major producer and exporter of branded pharmaceuticals and health-supplement products, with 6,600 employees and a presence in 33 countries.
Listed on the Stock Exchange of Thailand since November 2013, Mega last year earned 1.14 billion baht in net profit, down 5% from the year before, on revenue of 11.13 billion, a gain of 9.3% from 2018.
“I’m not a hero in this company,” Mr Dhawan tells Asia Focus. “In a team, everybody is good. A good company can only succeed when we have people who are better than me. … You need good people around who can actually pass the ball to somebody else, not you. If you do that then you are selfish. You can’t win.
“Creating a good team is what I’m thinking about; that’s where the word coach came from. You found that at Barcelona when Pep (Guardiola) was there. You found that at Arsenal with what (former manager) Arsène Wenger used to do,” he says.
“But there are different models. I’m not saying the other model is wrong but our model is that as a team, we win together. Everybody is important, the goalkeeper or the front guys, not that there is one hero.”
At Mega, which includes the fast-growing Maxcare logistics business serving Vietnam, Cambodia and Myanmar, Mr Dhawan’s goal if for everybody to enjoy coming to work.
“Work should not be painful,” he says. “The first thing I would say is that if I can enjoy it, everybody should enjoy work. They are smiling. If they are having fun then they give their best. Actually they are owners (of the company) so we make them feel they are the real owners, make them really feel good and they respond with honesty. (When we fight), we fight for the right reason. We don’t fight for politics.”
The company has four levels of staff — coaches, partners, associates and colleagues. This corporate culture, he says, was established 25 years ago.
“Most of these people have worked with me for a long time and they know what we have been through,” he explains. “We have decided that as a company, rather than having a director or vice-president, now we have coaches, partners, associates and colleagues. People can change from colleagues to associates, to partners and then they grow up to become coaches.
“What is my biggest job? It’s like playing (football). If we look at Arsenal, Manchester United or Barcelona, the coach is doing what? They let people play. Pep could not play for (Lionel) Messi. … Messi is one great player but you still need other players. He can’t play alone.
“I’m a coach. What does the coach do? They help people play as teams. Twenty-five years ago, I said we should have a model that says your job is to help other people to succeed, not me. If they succeed, I will succeed anyway, right?”
He offers an example of how the team should work. “I have a person who is very good in Thailand, I have a person who is good in manufacturing, regulatory affairs, people who are good in digital, and some who are very good in finance. All of them are good but they have to work together; then you can create a magical outcome.
“My job is to make sure that all of them work and play together for one reason because they love Mega. … That’s why I think my job is more like a coach, less like a CEO,” he says.
“I cannot tell them … do it now, shut up. That model doesn’t work anymore. That’s why I thought the coaching model is a better way. If they believe in the culture, then they will do the right thing. So creating that belief system is very important.”
The corporate culture was clearly illustrated when the Covid-19 pandemic started to seriously affect businesses all over the world including Mega. “When Covid happened, our factories were working every day. Our team in Thailand, with 2,000 people, had to come to work. They go to pharmacies, to hospitals, to deliver products. They do this all the time.”
“Even with Covid, nobody says, ‘I’m going home’. It’s people’s passion. They love what they’re doing. They do wonderful things. We’re not in a hurry to create sales, we are first creating belief. If there is belief, they will love what they do.”
STRATEGIC SHIFT
Born in India, Mr Dhawan earned his MBA in the United States and joined Medicap, a producer of soft pharmaceutical capsules in Thailand, in 1986. The company, with a plant in Bang Pu, Samut Prakan, later became Mega LifeSciences after it began to branch out into own-brand products in the mid-1990s.
In 1992, Medicap became the only Thai company with approval from the Australian Therapeutic Goods Administration, the country’s food and drug regulator. Since then Mr Dhawan has built a large, publicly listed company that is the number one supplement maker in both Thailand and Myanmar.
“This business was started in 1984-85 by two partners — a Thai group and an Indian partner who had technology. It was called Medicap. I came in 1986 after finishing my MBA. My father is an engineer who was based in Thailand. We joined them with some ownership and to manage the business,” he recalls.
“At that time, it was 10 people and maybe US$100,000 (2-3 million baht) in turnover, two machines, losing money. That’s where my journey started, as an engineer. My life began there from slowly, little by little growing and building it. We learned and we grew.”
From 1992-94, the company had to decide whether to continue being a contract manufacturer or pursue building its own brand. It chose the latter path.
“In the following 5-10 years, we did less and less OEM (original equipment manufacturing) and more and more of our own brands. We expanded to more and more markets,” says Mr Dhawan. “Then we started distribution. We went to Vietnam in 1993, then we opened Cambodia.”
Australia was the first foreign country where Mega set up manufacturing, on a site about 80 kilometres outside of Melbourne. With an investment of around 450-500 million baht, the company has also invested in a new plant in Bang Pu.
In February this year, Mega acquired a plant in Indonesia, outside Jakarta, as its third manufacturing facility. In Myanmar, it has a joint venture with an Indian partner to make new drugs. The project, however, is under review as Myanmar passed a new patent law last year.
“That plant is designed to produce new molecules. There have been some changes with medicine patents. And because of Covid, we cannot have meetings so we cannot get together with the team and can’t go to Myanmar but the land is there,” says Mr Dhawan.
Mega’s Maxcare division, however, has a major presence in Myanmar with warehouses covering 50,000 square metres in Yangon. Serving both pharmaceutical and fast-moving consumer goods, Maxcare represents companies including L’Oréal and Osotspa, as well as other food and cosmetics makers with coverage of 35,000 sales outlets in the country. “In total, we are in six cities and cover 60% of the country directly,” he says.
Beyond Asia, Mega has developed a presence with its own brand in sub-Saharan Africa with offices in Nigeria, Ghana, Kenya, Tanzania, Uganda and Ethiopia. Its other markets include Ukraine and Uzbekistan, and some parts of Latin America such as Peru and Colombia.
“We’ve invested in the countries where we are because we want to make our brand strong,” he says. “Wherever we are, we have a reasonably good presence. We have good brands. If you go to that market, you’ll find Mega WeCare in most of the markets.
“If you are in Myanmar, you will see Mega brands everywhere, so we are building long-term brands in the country. Brands that are part of your life, brands that consumers actually love.”
Nowadays, 95% of Mega’s manufacturing is for its own brands, thanks to the strategic shift it began pursuing more than 25 years ago. “It was our strategic shift. We shifted our business model to marketing our own brands.”
And while Covid has hit every business badly, Mr Dhawan says Mega has been quite resilient in the face of the ongoing crisis given its low debts, diversified markets and credible products. “Mega went through a lot of these difficult times [in 1997-98] when we borrowed some money in dollars and it became 56 baht to the dollar, but this is a part of life, right?
“We lived through it and we learned. It taught us. Every time you have something, you get to learn and you get better. But by building a resilient company, when you do the right thing in the same business again and again, you have a good chance of doing better. We get better by the day.”
But the more challenging task is to create something that can live and grow beyond his era. “I have written down my company philosophy, which is to build a thinking organisation that we can change before being forced to change,” he explains.
The key is to create a learning culture so that people in the company want to seek more knowledge. “We must start to question, to ask why. And when we ask why, we can make the right changes. Change before you are forced to, not when you have problems,” he points out. “Today everybody can change but can we do it before it’s too late?”
For example, Mega has been moving into digital marketing, and had already built a digital ecosystem before the pandemic happened. “How can you create something that is going to live on even when you are not here? It’s an ecosystem where good people will come and new things will happen and carry on even after I’m gone. That’s the biggest challenge for me these days.”
LEISURE TIME
When he has free time, Mr Dhawan reads avidly. “There is a lot to read and I read everything. I read philosophy, for example, The Tibetan Book of Living and Dying by Sogyal Rinpoche. We say that people prepare in this life to leave but they never prepare to die. Imagine today is your last day in this world, what will you do? You will do things differently. You will do good everyday,” he says.
“I also read a lot of philosophy, from Buddhism to Hinduism, and history.”
To keep in touch with what is happening in the business world and gain new insights, he also reads the Harvard Business Review and magazines.
“At the moment I’m fascinated by behavioural science. I read a book called Nudge by Richard Thaler (and Cass Sunstein), about rationality in behaviour. We think people’s behaviours are rational but in fact they’re not. I’m reading a lot of studies by behavioural scientists now to get into human behaviours.
“Now that Covid has shaken the world, the way people behave in a time of pandemic and what kinds of responses they have in their behaviours, are interesting. For example, how do you spend your money during such a time?”
Another area he is attracted to is creativity. “I just heard about another interesting book called Creative Confidence by Tom and David Kelley. It’s about how everybody has a chance to be creative. How can we help people to bring that out in them?”
Wellness is another interest, and a book entitled Undo It (by Dean Ornish and Anne Ornish) struck a chord. It proposes that you can “undo” your diseases if you make changes in your daily life.
As Mega’s business is well diversified, Mr Dhawan has a lot of chances to travel, and that is another thing he is passionate about. “Every country is so beautiful. When I went to Vietnam 25 years ago, in Hanoi, there was a small shop and they make only one dish called cha ca. (noodles with fish) and it’s 100 years old,” he recalls.
In Bhutan, he remembers walking for five days on a winter trek from Thimphu to Paro. “Every day, I walked 10 kilometres and slept in a tent, freezing. But Bhutan is so beautiful.”
He finds Italy lovely, particularly the countryside. In India, he rode the Maharajah Express for six days to see many cities. Business has also taken him to African nations such as Tanzania and Ethiopia. “In Ethiopia you eat corn on the street — they roast it for you over charcoal. I think every country got some magic in it.
“Beauty is everywhere. Stop measuring it. If you compare — this is better or I love this more than something else — that’s a challenge. Beauty is what you enjoy when you are there. Wherever you are, that is beautiful.”
His next trip is to Latin America, which offers a lot of ground to cover. “Everything in Latin America needs time. I want to travel around, have more time to do that. Today with work, I don’t go (on holiday) for a month. I go for two weeks. I do two two-week holidays a year at least.
“I love history. I love walking around. I want to see and feel the cultures of other countries,” he says with a smile. “I would love to go to all the old places where you can still feel the local energy, smell the food, enjoy the people walking around, the warmth of it. This is kind of thing I enjoy for my holidays.”
Bangkok Post : https://www.bangkokpost.com/business/1958127/team-player
Mr. Vivek Dhawan, Chief Executive Officer and Chief Coach of Mega Lifesciences Public Company Limited (MEGA), a global Fast Moving Consumer Goods (FCMG) provider, announced the company’s business strategies in all areas to support healthy living for people worldwide. MEGA is reviewing potential acquisitions to further strengthen its regional presence. The company is also focusing on developing countries in Southeast Asia, Central and Latin America, sub-Saharan Africa and CIS countries that offer strong growth potential to double its business by 2025. MEGA’s annual revenue increased by 12.1% from 2010 to 2018, while the company’s normalized net profit increased 19.4% in the first quarter of 2019.
Yangon, Myanmar, 9 June 2018 – Maxxcare Ltd, the distribution arm of Mega Lifesciences Group, has inaugurated a 120,000 square-foot distribution center in Yangon that will raise the bar for pharmaceutical distributors in Myanmar.
H.E U Phyo Min Thein, Chief Minister of Yangon Region, H.E Khun Pakainay Lengee, Minister Counsellor (Commercial) of Royal Thai Embassy, Dr. Khin Zaw, Director General of Food and Drug Administration, Ministry of Health and Sports along with Mr Vivek Dhawan, CEO & Chief Coach of Mega Lifesciences Group, and Mr Girish Wadhwa, President and Head Coach of Mega Lifesciences, cut the ribbon to inaugurate the facility.
Maxxcare’s Yangon Distribution Center is one of the largest facilities of its kind in Myanmar, stretching over 11 acres of land in northern Yangon. It currently has 120,000 square feet of warehouse capacity and another 38,000 square feet for utilities, modern office space and a canteen. It is expected to be fully operational by July 9, 2018.
Mr. Vivek Dhawan said: “Our commitment to providing the best in class distribution services for pharmaceutical and consumer goods to the people of Myanmar is affirmed by this new Distribution Center. Ensuring quality medicines and consumer goods are delivered to every corner of the country.” He added: “We remain focused on bringing new, innovative and quality medicines and products to everyone in the country.”
The Yangon Distribution Center can store about 700,000 shipping cartons in its modern, six-level, nine-meter-high racking system. Pharmaceutical products will be stored in air-conditioned warehousing space, while the center also includes a cold
chain storage facility for products such as vaccines, insulin and other drugs that require a stable temperature of 2-8 degrees Celsius.
Safety has been a primary consideration in the design of the Yangon Distribution Center, which features a fire safety system with a sprinkler system and 80,000 gallons tank.
The next initiative for the facility is to install a 400-kilowatt rooftop solar plant which is capable of generating about 600,000 kilowatt hours per year, thus preventing an estimated 11,340 tons of carbon dioxide emissions. Mr Girish Wadhwa said: “Our investment in the new Yangon Distribution Center reflects our deep commitment to the country and our vision of a strong future for our operations in Myanmar. We have designed and built this facility with a clear objective to ensure highest quality of services and to secure capacity for future growth.”
This 18.8-billion-kyat investment into the Distribution Center also includes the implementation of the solar project as well as adding another 80,000 square feet of storage capacity at the center over the next five years, an expansion that would almost double its initial capacity.
Mega Lifesciences has been supporting deserving students in Universities of Medicine and Pharmacy through the Ministry of Sports and Health since 2006. Mr Vivek Dhawan received an appreciation certificate from Daw Tin Tin Lay, Director General, Department of Human Resources, Ministry of Health and Sports for the 10.8 million kyat donated by Mega towards the scholarship for the academic year 2018-19.
Aconotin 10mg and Aconotin 20 mg (‘Aconotin’) currently sold by Mega Lifesciences Public Company Limited (‘Company’) through its 100% subsidiary Mega Lifesciences PTY Limited are controlled drugs under the regulations announced by Food and Drug Administration (FDA) of Thailand. These products can be procured by patients only under prescription by a qualified dermatologist in a hospital or clinic. These products are not over The Counter (OTC) products and may involve health hazards if consumed without prescription. Company sells Acnotin strictly according to the FDA regulations.
Company bears no responsibility For Acnotin that may be sold at any pharmacies or by any one on the internet or advertised for any properties of this product. The company has no method to dertermine that the product is genuine and the quality of such Products can not be guaranteed and the company will not take responsibility for any consequences of using the Product.
Any person who, directly or indirectly, sells of solicits to sell Acnotin without permission from the company is violation of the regulations of FDA and also the intellectual property of the Company. The Company reserves the right to take legal action against the violator(s).
MEGA LIFESCIENCES, a Thai pharmaceutical firm, celebrated 20 years of operations and US$100 million (Bt3.5 billion) of business the company and its partners have secured since its inception in Myanmar.
“From starting on a very small scale in 1995, to now having 1,400 staff, eight offices and presence in 50 towns and cities in Myanmar, we are grateful to celebrate two decades here,” Vivek Dhawan, CEO and chief coach, said yesterday.
Mega derived 32.3 per cent of its sales from Myanmar last year.
The pharma has become a successful case study for international corporations doing business in that country.
“This growing market represents our top country by revenue of all the 31 countries where Mega Lifesciences is found.
“We are proud to be able to help local people with their health and wellness and we thank Myanmar for its support,” he said.
The large pharma distributes pharmaceuticals, vitamins and consumer products in the neighbouring country.
Now with more than 70 commercialised products, Mega leads the iron, calcium, vitamin E and liver supplement markets.
It is also the leading pharmaceutical and fast-moving-consumer-goods distribution company, representing more than 30 principals such as Kimberly-Clark, Pfizer, MSD, GSK Consumer Health and Sandoz under its Maxxcare arm.
Mega was the first international company to set up distribution operations in Myanmar and now represents roughly 15 per cent of the nation’s total pharmaceutical market.
To commemorate the occasion, a gala took place at the Myanmar Convention Centre in Yangon with more than 1,000 employees, partners and guests attending.
Mega forecasts continued double-digit growth over the five years until 2020 and hopes to expand its distribution network in Myanmar in line with growth estimates for the country.
Vitamins and supplements are the largest therapeutic category in this country of 53 million, accounting for about a quarter of the market.
“When we started in Myanmar, we wanted to make a difference in developing markets where there was a need to create access to world-class healthcare products,” Dhawan said.
“We were steadfast in our business-expansion decision to be one of the first into developing nations and grow as they expand.
“Thanks to this, Mega has experienced 10-to-15-per-cent growth annually in Myanmar.”